Archiwum hase³
Oxygen toxicity | multicellular organisms | pulmonary actinomycosis | retinopathy of prematurity {ROP} | midland disease | insulin resistance | inflammatory biomarkers | insulin resistance index {HOMA-IR} | laparoscopic adrenalectomy | functioning adrenal tumours | non-functioning adrenal tumours | transperitoneal approach | retroperitoneal approach | indication for surgery | blood loss | open adrenalectomy | autoimmune thyroiditis | chronic viral hepatitis type C | alpha interferon | pegylated alpha interferon | thyrotrophin | free tyrosine | antithyroid antibodies | thyroid echostructure | brain natriuretic peptide | overt hypothyroidism | subclinical hypothyroidism | NT-pro-brain natriuretic peptide{NT-pro-BNP} | thyrometabolic state | methimazole | precipitation method | ultrafiltration method | functional hyperprolactinaemia | precipitation cut-off point | densitometry | peak bone mass | postmenopausal osteoporosis | oestrogen deficiency | juvenile depression | hypothalamic neurosecretion | secondary hypo-oestrogenism | hypoestrogenism | hypo-oestrogenism | dysphagia | predictive factors | vasculogenesis | marfanoid features of body | altered echostructure | increased expression of somatostatin receptors | Carney complex | isolated familial somatotropinoma {IFS} | familial isolated pituitary adenomas {FIPA} | pituitary macroadenoma | Klinefelter’s syndrome | progressive infiltrative ophthalmopathy | Graves’ ophthalmopathy | infiltrative form of Graves’ ophthalmopathy | pulse treatment | ophthalmopathy index | indices of metabolic syndrome | insulin sensitivity/ resistance indices | paroxysmal hypertension | malondialdehyde | non-autoimmunological subclinical hyperthyroidism | jejunal stromal tumour | metastatic neuroendocrine cancer | hyperechogenic foci | somatostatin receptor | peptide-receptor targeted radionuclide therapy | synaptophysin | heart rate variability | hypergonadotropic | hypogonadotropic | anabolic androgenic steroids | prohibited doping agents | doping agents | estrogen receptor expression | estrogen receptor | somatostatin receptor subtypes | expression of somatostatin receptor | long-acting somatostatin analogues | lanreotide | hormonal phenotype | gonadotropinoma | corticotropinoma | ventilatory threshold | streptozotocin | Greenhouse-Geisser test | androgen receptor gene CAG trinucleotide sequence polymorphism | androgen receptor {AR} | pituitary autoantibodies | pituitary autoantibodies | affinity chromatography | recall bias | interventricular septum thickness | left ventricular mass index | self-discrepancy theory | hormonal regulation of feeding | regulation of feeding | somatotrophic axis | somatotropic axis | osteoprotegerin | pituitary autoantigen | echocardiographic assessment of myocardial function | subacute thyroiditis | thyroid ultrasound examination | diagnostic errors | long muscle of the neck | sternocleidomastoid muscle | sternohyoid muscle | sternothyroid muscle | homogeneous echogenicity | well-defined borders | ill-defined borders | acoustic shadow | massive calcification | status after radioiodine treatment | markedly increased thyroid blood flow | comet-tail artefact | hyperechogenic nodule | hypoechogenic nodule | spongiform appearance | „egg-shell” or rim calcification | sonoelastography | papillary microcarcinoma | thyroid hemiagenesis | compensatory enlargement | ectopic lingual thyroid | scintiscan | thyroglossal duct cyst | microcalcifications | extracapsular location | reactive lymph node | polycyclic metastatic lymph nodes | impaired glucose tolerance {IGT} | fasting glycaemia | fine needle aspiration biopsy {FNAB} | cellular glucose transport | pre-diabetic state | glucotransporter expression | hyperbaric oxygen therapy {HBOT} | urinary iodine concentration( {UIC} | zinc deficiency | desmopressin stimulation test | hypercortisolaemia | transsphenoidal selective adenomectomy | hemiplegia | long-standing stroke | Barthel index | standing-up | cohort study | anthropometric indices | anthropometric parameters | salmon calcitonin | alcian blue | growth plate | intervention thresholds | low-energy fractures | osteoporotic fracture | mean bone mineral density | ibandronate | post-menopausal period | oestrogen-dependent tissues | strontium ranelate | post-menopausal osteoporosis | extravertebral fractures | bone formation markers | antiresorptive treatment | parathyroid hormone | non-vertebral fractures | primary end point | atypical subtrochanteric fracture | fatigue fractures | atypical fractures | increased uptake of marker | marker of the pre-diabetic state | mean platelet volume {MPV} | fasting blood glucose | high sensitivity C-reactive protein | mean platelet volume | normotensive patients | hormonal function of adipose tissue | panhypopituitary insufficiency | Chitayat-Hall syndrome | agenesis of corpus callosum | tracheo-laryngeal hypoplasia | Wolf-Hirschhorn syndrome | subtelomeric deletions | congenital distal limb contractures | panhypopituitarism | high myopia | extraocular muscle | cover test | orthophoria | esotropia | anatomical axial eyeball lenght | angle of strabismus | binocular vision | causative factors | negative civilizational influence |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
